患有化脓性汗腺炎患者的眼部合并症负担。
Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa.
机构信息
Department of Surgery, University of Maryland, Baltimore.
Dermatology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
出版信息
JAMA Dermatol. 2021 Feb 1;157(2):226-227. doi: 10.1001/jamadermatol.2020.5087.
Abstract
This case-control study examines the burden of ocular comorbidities in patients with hidradenitis suppurativa.
摘要
本病例对照研究探讨了化脓性汗腺炎患者眼部合并症的负担。
相似文献
1
Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa.
JAMA Dermatol. 2021 Feb 1;157(2):226-227. doi: 10.1001/jamadermatol.2020.5087.
2
Hidradenitis Suppurativa in Down Syndrome: A Case Series.
Pediatr Dermatol. 2017 Jul;34(4):461-464. doi: 10.1111/pde.13188. Epub 2017 Jun 21.
3
Patients with hidradenitis suppurativa have no increased risk of Alzheimer disease.
Br J Dermatol. 2017 Jul;177(1):273-275. doi: 10.1111/bjd.15064. Epub 2017 May 23.
4
Features of Patients With Crohn's Disease and Hidradenitis Suppurativa.
Clin Gastroenterol Hepatol. 2016 Jan;14(1):71-9. doi: 10.1016/j.cgh.2015.04.180. Epub 2015 May 5.
5
Prevalence of obstructive sleep apnea with hidradenitis suppurativa: a matched case-control study.
Arch Dermatol Res. 2024 Apr 17;316(5):121. doi: 10.1007/s00403-024-02869-6.
6
Diagnosing Hidradenitis Suppurativa.
Dermatol Clin. 2016 Jan;34(1):1-5. doi: 10.1016/j.det.2015.08.009.
7
Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.
Arch Dermatol Res. 2021 Mar;313(2):95-99. doi: 10.1007/s00403-020-02065-2. Epub 2020 Apr 22.
8
The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease.
Br J Dermatol. 2014 Sep;171(3):673-5. doi: 10.1111/bjd.13002. Epub 2014 Jul 22.
9
Treatments for Hidradenitis Suppurativa Comorbidities Help With Pain Management.
Cutis. 2023 Sep;112(3):112-113. doi: 10.12788/cutis.0848.
10
Risk factors associated with hidradenitis suppurativa comorbid with inflammatory bowel disease and clinical phenotypes: a pilot case-control study.
Int J Dermatol. 2023 Jun;62(6):e339-e341. doi: 10.1111/ijd.16311. Epub 2022 Jun 20.
引用本文的文献
1
Hidradenitis Suppurativa and Ocular Diseases: Real-world Evidence of 57,972 Patients.
Acta Derm Venereol. 2025 May 19;105:adv42716. doi: 10.2340/actadv.v105.42716.
2
Australasian hidradenitis suppurativa management guidelines.
Australas J Dermatol. 2025 Mar;66(2):75-89. doi: 10.1111/ajd.14388. Epub 2024 Nov 22.
3
Risk of Keratitis and Keratopathy in Hidradenitis Suppurativa Patients: A Global Federated Health Network Analysis.
In Vivo. 2024 May-Jun;38(3):1375-1383. doi: 10.21873/invivo.13578.
4
Interstitial keratitis presenting as the ocular manifestation of undiagnosed hidradenitis suppurativa.
Proc (Bayl Univ Med Cent). 2024 Feb 28;37(3):479-481. doi: 10.1080/08998280.2024.2315540. eCollection 2024.
5
Retinal Microvascular Alterations in Hidradenitis Suppurativa Patients: A Pilot Study Using Optical Coherence Tomography Angiography.
J Clin Med. 2024 Mar 2;13(5):1464. doi: 10.3390/jcm13051464.
6
The Relevant Oral Burden of Patients with Hidradenitis Suppurativa.
Dermatol Ther (Heidelb). 2023 Oct;13(10):2319-2329. doi: 10.1007/s13555-023-01006-x. Epub 2023 Aug 31.
7
Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review.
J Family Med Prim Care. 2021 Nov;10(11):4009-4016. doi: 10.4103/jfmpc.jfmpc_795_21. Epub 2021 Nov 29.
8
The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study.
Life (Basel). 2021 Jul 15;11(7):697. doi: 10.3390/life11070697.
9
Error in Author Name.
JAMA Dermatol. 2021 Feb 1;157(2):240. doi: 10.1001/jamadermatol.2021.0069.
Zotero 插件